CRA Financial Services’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $2.28M | Buy |
9,077
+214
| +2% | +$46K | 0.26% | 78 |
|
|
2026
Q1 | $1.93M | Sell |
8,863
-310
| -3% | -$68.8K | 0.25% | 80 |
|
|
2025
Q4 | $2.1M | Sell |
9,173
-467
| -5% | -$106K | 0.27% | 74 |
|
|
2025
Q3 | $2.23M | Buy |
9,640
+267
| +3% | +$54.4K | 0.31% | 67 |
|
|
2025
Q2 | $1.74M | Buy |
9,373
+69
| +0.7% | +$12.8K | 0.27% | 75 |
|
|
2025
Q1 | $1.95M | Sell |
9,304
-1,686
| -15% | -$328K | 0.33% | 59 |
|
|
2024
Q4 | $1.95M | Sell |
10,990
-332
| -3% | -$61K | 0.34% | 55 |
|
|
2024
Q3 | $2.24M | Sell |
11,322
-14
| -0.1% | -$2.61K | 0.41% | 45 |
|
|
2024
Q2 | $1.94M | Sell |
11,336
-92
| -0.8% | -$15.2K | 0.39% | 46 |
|
|
2024
Q1 | $2.08M | Buy |
11,428
+10
| +0.1% | +$1.72K | 0.45% | 40 |
|
|
2023
Q4 | $1.77M | Buy |
11,418
+27
| +0.2% | +$3.94K | 0.43% | 46 |
|
|
2023
Q3 | $1.7M | Buy |
11,391
+2,355
| +26% | +$346K | 0.47% | 44 |
|
|
2023
Q2 | $1.22M | Buy |
9,036
+162
| +2% | +$23.8K | 0.33% | 56 |
|
|
2023
Q1 | $1.41M | Buy |
8,874
+281
| +3% | +$43K | 0.42% | 48 |
|
|
2022
Q4 | $1.39M | Sell |
8,593
-387
| -4% | -$59.3K | 0.45% | 46 |
|
|
2022
Q3 | $1.21M | Sell |
8,980
-100
| -1% | -$14.3K | 0.43% | 46 |
|
|
2022
Q2 | $1.39M | Buy |
9,080
+20
| +0.2% | +$3.06K | 0.48% | 40 |
|
|
2022
Q1 | $1.47M | Buy |
9,060
+1,939
| +27% | +$282K | 0.44% | 41 |
|
|
2021
Q4 | $964K | Sell |
7,121
-48
| -0.7% | -$5.67K | 0.29% | 65 |
|
|
2021
Q3 | $773K | Buy |
7,169
+410
| +6% | +$46.8K | 0.26% | 76 |
|
|
2021
Q2 | $761K | Buy |
6,759
+1,048
| +18% | +$118K | 0.26% | 79 |
|
|
2021
Q1 | $618K | Sell |
5,711
-7
| -0.1% | -$749 | 0.24% | 84 |
|
|
2020
Q4 | $613K | Buy |
5,718
+319
| +6% | +$30.7K | 0.26% | 83 |
|
|
2020
Q3 | $473K | Sell |
5,399
-173
| -3% | -$16.3K | 0.23% | 86 |
|
|
2020
Q2 | $547K | Buy |
5,572
+199
| +4% | +$17.5K | 0.29% | 76 |
|
|
2020
Q1 | $409K | Buy |
5,373
+301
| +6% | +$25.6K | 0.26% | 83 |
|
|
2019
Q4 | $449K | Buy |
5,072
+1,707
| +51% | +$142K | 0.25% | 85 |
|
|
2019
Q3 | $255K | Buy |
3,365
+309
| +10% | +$21.2K | 0.15% | 118 |
|
|
2019
Q2 | $222K | Sell |
3,056
-37
| -1% | -$2.91K | 0.13% | 126 |
|
|
2019
Q1 | $249K | Buy |
3,093
+598
| +24% | +$48.9K | 0.16% | 118 |
|
|
2018
Q4 | $230K | Buy |
+2,495
| New | +$219K | 0.17% | 120 |
|
Other funds holding ABBV
CRA Financial Services's ABBV Position: Q2 2026 in Review
CRA Financial Services increased its AbbVie (ABBV) stake by 2.4% in Q2 2026, buying an estimated $46K and bringing the position to 9,077 shares worth $2.28M. The position accounts for 0.26% of the portfolio, ranked #78.
CRA Financial Services first reported a position in ABBV in Q4 2018 and has held it in 31 quarters since. 4,201 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.
- CRA Financial Services held 9,077 shares of AbbVie worth $2.28M as of Q2 2026.
- CRA Financial Services bought 214 AbbVie shares in Q2 2026, an estimated $46K.
- AbbVie made up 0.26% of CRA Financial Services's portfolio in Q2 2026, its #78 holding.
- CRA Financial Services first reported a position in AbbVie in Q4 2018 and has held it in 31 quarters since.
- 4,201 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.
Based on CRA Financial Services's 13F filing for Q2 2026, filed 24 Jul 2026.